News
If you want to "wow" your eyelashes, you may be tempted to get extensions, though risks are involved, say experts.
New understanding of a receptor key to allergic responses and anaphylaxis in conditions like asthma could offer a new treatment target for sufferers of a variety of conditions. This the promise of ...
Becoming the first approved treatment for chronic hand eczema in the U.S., Leo Pharma A/S’s Anzupgo (delgocitinib) received FDA clearance for an indication that affects 10% of adults worldwide. The ...
LEO Pharma Inc. announced today that the Food and Drug Administration (FDA) has approved ANZUPGO® (delgocitinib) cream for the topical treatment of moderate-to-severe chronic hand eczema (CHE) in ...
Have itchy eyes? You may have developed eyelid eczema, which affects many people with eczema. Here are three signs that you have it.
Apogee Therapeutics’ anti-IL-13 antibody has been tied to a 71% reduction in eczema severity after 16 weeks, hitting the main goal of a phase 2 trial.
On June 24, Nektar Therapeutics announced positive results from its mid-stage REZOLVE-AD study for rezpegaldesleukin, which is an eczema treatment.
Nektar Therapeutics (NASDAQ:NKTR) is one of the best hot stocks to buy according to Wall Street analysts. On June 24, Nektar Therapeutics announced positive results from its mid-stage REZOLVE-AD ...
Rezpegaldesleukin (Rezpeg) shows fast, effective eczema relief in Phase 2 trial with fewer side effects than other treatments, offering hope for moderate-to-severe cases.
I’ve had to learn that just because I don’t have eczema myself, it doesn’t mean I can remain ignorant about it and the effect it has on my kids. Not if I want to help them.
If dry eyelids persist or are accompanied by redness, flaking, or itching, schedule an evaluation at your dermatologist's office to rule out eczema or other chronic conditions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results